Reagent Kit for Detection of SARS-CoV-2 RNA Causing Severe Respiratory Infection Using PCR with Hybridization-Fluorescent Detection “SBT-DX-SARS-CoV-2”, Batch 330-265

Reagent Kit for Detection of SARS-CoV-2 RNA Causing Severe Respiratory Infection Using PCR with Hybridization-Fluorescent Detection “SBT-DX-SARS-CoV-2”, Batch 330-265

The “SBT-DX-SARS-CoV-2” reagent kit is intended for the qualitative detection of SARS-CoV-2 viral RNA in biological samples using polymerase chain reaction (PCR) with hybridization-fluorescent detection.

• 2× RT-PCR-RV Buffer – 3 tubes (1.4 mL each)
• BioMaster Mix – 1 tube (0.35 mL)
• Positive Control Sample 3CL (PCS 3CL) – 1 tube (0.1 mL)
• Fluorescent Mix C – 1 tube (1.1 mL)
• Fluorescent Mix V – 1 tube (1.1 mL)
• Water – 1 tube (1.3 mL)
• Instructions for use
• Product passport

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Detection of SARS-CoV-2 RNA Causing Severe Respiratory Infection Using PCR with Hybridization-Fluorescent Detection “SBT-DX-SARS-CoV-2”, Batch 330-265, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.